Angiodroid

San Lazzaro, Italy

Angiodroid is a medtech company offering an automatic injection system for carbon dioxide angiography.

$7.4M raised

Feb 2023

Series A

Top Investors

CDP Venture CapitalInnogest CapitalItalian Angels for Growth8a+ Investments SGRAir Liquide ALIAD

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Angiodroid raised?

Angiodroid has raised $7.4M in total funding. The most recent round was Series A. The last funding was announced in February 2023.

Who are Angiodroid's investors?

Angiodroid's investors include CDP Venture Capital, Innogest Capital, Italian Angels for Growth, 8a+ Investments SGR, Air Liquide ALIAD.

Where is Angiodroid headquartered?

Angiodroid is headquartered in San Lazzaro, Italy.

What does Angiodroid do?

Angiodroid is a medtech company offering an automatic injection system for carbon dioxide angiography.

What stage is Angiodroid at?

Angiodroid is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 27, 2023.

MLA

"Angiodroid — Funding & Investors." VCBacked, February 27, 2023, https://www.vcbacked.co/company/angiodroid. Accessed June 4, 2026.

APA

VCBacked. (2023). Angiodroid — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/angiodroid

Wikipedia (cite web)

{{cite web |title=Angiodroid — Funding & Investors |url=https://www.vcbacked.co/company/angiodroid |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 27, 2023.